Search Results 2061-2070 of 18535 for ectopic-pregnancy
Females who are pregnant, breastfeeding, or who are trying to become pregnant. Not willing to use a reliable form of contraception (for women of ...
Note: Prior glepaglutide trial drug is allowed. Females of childbearing potential, who are pregnant, breast-feeding, intend to become pregnant, or are not using ...
Negative pregnancy test (serum or urine) done ≤ 14 days prior to registration, for persons of childbearing potential only. Provide written informed consent ...
Not pregnant and not nursing ... For women of childbearing potential only, a negative pregnancy test done ≤ 5 days prior to registration is required.
Should a woman become pregnant or suspect she is pregnant while she or her partner is participating in this trial, the treating physician should be informed ...
Female patients of childbearing potential must have a negative serum beta-human chorionic gonadotropin (β-hCG) pregnancy test within 28 days prior to the start ...
If female and of child bearing potential, have a negative pregnancy test prior (within 48 hours) to participating in the study. ... Females who are pregnant.
Pregnant and lactating females will be excluded (Women of child bearing potential will have a urine pregnancy test administered prior to the MR elastography ...
Negative pregnancy test done ≤ 7 days prior to registration, for persons of childbearing potential only. Persons able to become pregnant OR able to father ...
Women of childbearing potential must have negative blood or urine pregnancy test at screening. Exclusion Criteria: Recent therapeutic interventions within 3 ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!